home
programs
directory by group
resources by island
links
contact us
National HIV/AIDS Clinicians' Consultation Center
U.S. State and Jurisdiction Information
Country and Region Information
Abacavir (Ziagen) Information
A Dose-Ranging Study to Evaluate the Safety and Efficacy of Abacavir Alone or in Combination with Zidovudine and Lamivudine in Antiretroviral Treatment-Naive Subjects (PDF)
Abacavir (Ziagen), Various Languages
Abacavir Pharmacokinetics in Human Immunodeficiency Virus–Infected Children Ranging in Age From 1 Month to 16 Years: A Population Analysis (PDF)
Abacavir Sensitivity (PowerPoint Slide Set)
Cellular Restoration in HIV Infected Persons Treated with Abacavir and a Protease Inhibitor: Age Inversely Predicts Naive CD4 Cell Count Increase (PDF)
Clinically Relevant Interpretation of Genotype for Resistance to Abacavir (PDF)
HIV-1 Genotype and Phenotype Correlate with Virological Response to Abacavir, Amprenavir and Efavirenz in Treatment-Experienced Patients (PDF)
HIV-1 Reverse Transcriptase Sequence in Plasma and Cerebrospinal Fluid of Patients with AIDS Dementia Complex Treated with Abacavir (PDF)
Low efficacy and High Frequency of Adverse Events in a Randomized Trial of the Triple Nucleoside Regimen Abacavir, Stavudine and Didanosine (PDF)
Low Efficacy and High Frequency of Adverse Events in a Randomized Trial of the Triple Nucleoside Regimen Abacavir, Stavudine and Didanosine (PDF)
Prednisolone Does Not Prevent Hypersensitivity Reactions in Antiretroviral Drug Regimens Containing Abacavir With or Without Nevirapine (PDF)
Reversibility of Lipoatrophy in HIV-infected Patients 2 Years After Switching from a Thymidine Analogue to Abacavir: The MITOX Extension Study (PDF)
Simplification with Abacavir-Based Triple Nucleoside Therapy Versus Continued Protease Inhibitor-Based HAART in HIV-1-Infected Patients with Undetectable Plasma HIV-1 RNA (PDF)
Ziagen® (Abacavir)
Back to HIV Medication Information Back to Non-English Information
Comments/questions about this site to: Kevin Patrick Site and banner created by David Flynn, UH Manoa
